Best Grants for HIV / AIDS in American Samoa

American Samoa HIV / AIDS and other poverty-focused entrepreneurs can access funding through D-Prize to launch new organizations distributing proven interventions, with startup grants up to Up to US $20,000. For-profit ventures, NGOs, and charities in low- and middle-income countries, especially first-time founders with limited prior funding, may be eligible.

Research institutions and multidisciplinary scientific teams in American Samoa studying the structural biology of HIV and other infectious diseases can apply for competitive grants from the National Institutes of Health. Funding supports advanced 3D structural analyses, molecular characterization, and structure-guided design of new diagnostics and therapeutics, which may benefit HIV/AIDS-focused programs and researchers.

Organizations planning substance use and HIV prevention or services research in American Samoa can access funding for pilot and feasibility studies supporting future trials. Grants from the National Institutes of Health help develop and test interventions, measures, and methods, with required engagement of end users such as policymakers, practitioners, and people with lived experience.

Research institutions studying HIV-related chronic conditions, coinfections, and comorbidities can access funding through grants from the National Institutes of Health. Early-career investigators may receive support for pioneering HIV prevention and treatment research, including work focused on pediatric and maternal populations, with eligibility extending to American Samoa and other U.S. territories.

American Samoa HIV/AIDS research institutions and investigators studying immunotherapies and brain health can access funding through the National Institutes of Health to evaluate how HIV immunotherapies affect central nervous system outcomes. This R21/R33 opportunity supports biphasic projects examining mechanisms, benefits, and risks, aiming to improve long-term neurologic and cognitive outcomes in people with HIV, with awards up to US $2,000,000.

Research institutions and clinical organizations conducting HIV/AIDS prevention and treatment studies in American Samoa and other eligible regions can access funding through the National Institutes of Health. Grants support participation as Clinical Trials Units within HIV/AIDS Clinical Trials Networks, including clinical research sites, implementation research, and infrastructure to recruit and retain study participants.

Research institutions with capacity to lead HIV clinical trial data operations can apply to manage Statistical and Data Management Centers serving global HIV Clinical Trials Networks, including work impacting American Samoa. American Samoa HIV / AIDS organizations partnering in clinical trials may benefit through improved data systems, monitoring, and analysis supported by the National Institutes of Health.

Research institutions and clinical laboratories working on HIV/AIDS prevention and treatment, including those serving American Samoa, can apply for National Institutes of Health support to operate HIV/AIDS Clinical Trials Network Laboratory Centers. Funding supports laboratory infrastructure, regulatory-compliant testing, data systems, and advanced assays to increase testing capacity for HIV and HIV-related diseases within multi-site clinical trials.

Research institutions focused on HIV/AIDS clinical trials and implementation research can apply to lead a Clinical Trials Network Leadership and Operations Center, including work relevant to American Samoa. Focused on HIV prevention, treatment, and cure strategies across populations, the National Institutes of Health supports LOCs providing scientific leadership and setting research priorities.

Research institutions conducting addiction and HIV science in American Samoa can apply for core center funding to build transformative, interdisciplinary research hubs. Focused on substance use, addiction, and HIV, the National Institutes of Health supports centers that integrate existing projects, share resources, foster early-career investigators, and promote collaboration and data sharing across funded teams.

Research institutions conducting HIV/AIDS studies in American Samoa can apply for U.S. Dept. of Health & Human Services National Institutes of Health support to develop and use specific pathogen free in vivo models and human new approach methodologies. Awards US $212,004 - US $2,725,311 fund NAMs-enabled stewardship frameworks, in vitro testing support, and high-quality SPF colony operations.

Research institutions conducting interdisciplinary HIV/AIDS mental health research in American Samoa can access funding through the National Institutes of Health. Grants from the National Institutes of Health help American Samoa HIV / AIDS organizations develop and sustain coordinated research centers advancing basic, clinical, behavioral, and implementation science. Eligible centers are expected to foster collaboration and disseminate findings to agencies and affected communities.

Organizations involved in HIV/AIDS prevention, care, and planning in American Samoa can access funding to strengthen integrated HIV services and resource allocation. Focused on improving HIV care systems, the Health Resources & Services Administration provides tools, training, and technical assistance through this cooperative agreement, with awards up to US $700,000.

The AIDS Drug Assistance Program (ADAP) Emergency Relief Funds aim to provide essential funding to states and territories. This initiative focuses on preventing, reducing, or eliminating waiting lists for ADAP services, ensuring timely access to necessary medications and support for individuals living with HIV/AIDS. This program addresses critical funding shortfalls, enhancing the healthcare infrastructure and improving health outcomes in affected communities.

The Ryan White HIV/AIDS Program Part C Capacity Development Program aims to enhance the capabilities of community-based organizations, focusing on improving health outcomes and decreasing HIV transmission. This initiative supports individuals who have not yet accessed regular HIV care, emphasizing innovative care solutions and infrastructure development to address these critical needs.

The HIV Care Grant Program, funded by the US HHS: Health Resources & Services Administration (HRSA), aims to enhance access to high-quality HIV care and treatment for low-income individuals. This initiative supports states and territories in developing comprehensive systems to address the needs of those living with HIV. By providing essential resources, the program seeks to improve health outcomes and ensure that vulnerable populations receive the necessary support and services.

The Ryan White HIV/AIDS Program Part B Supplemental Grant aims to provide essential funding to support HIV care and treatment services across states and territories. This program supplements existing formula-based funding from the RWHAP Part B and ADAP, improving access to necessary resources for those affected by HIV/AIDS. By enhancing support structures, it addresses critical healthcare needs, ensuring better health outcomes for vulnerable populations.

The HIV Care Grant Program aims to enhance access to comprehensive, high-quality HIV care and treatment for low-income individuals in Pacific Island territories. Funded by the US HHS: Health Resources & Services Administration (HRSA), this initiative supports states and territories in developing effective systems of care, ensuring that those affected by HIV receive the necessary treatment and support to improve health outcomes.

This funding opportunity aims to enhance a web-based ordering portal for distributing 1.5 million HIV and STI self-tests to high-burden communities. By optimizing access to these self-tests, the initiative seeks to raise awareness, prevent new infections, and improve the health outcomes of users, thereby contributing to better overall public health and wellbeing.

This project aims to enhance health outcomes for women living with HIV in the South by integrating HIV care with comprehensive women's health services through coordinated Clinic and Community Collaboratives. By funding organizations to implement targeted strategies such as culturally responsive services and learning collaboratives, the initiative seeks to improve access to essential health services, increase the number of women initiating rapid ART, and foster sustainable healthcare models that address the unique needs of this population.

The Ryan White HIV/AIDS Program Part D provides supplemental funding aimed at enhancing the infrastructure and capacity of organizations to deliver high-quality, family-centered HIV care services. This initiative focuses on two key areas: HIV Care Innovation and Infrastructure Development, ensuring improved access to essential services for women, infants, children, and youth affected by HIV.

The Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program Training and Technical Assistance aims to enhance the capacity of ADAPs. By providing essential tools and expert guidance, the program seeks to improve health outcomes for individuals living with HIV in an evolving healthcare landscape. This initiative is funded by the US HHS through the Health Resources & Services Administration, ensuring support and resources are effectively allocated to meet the needs of vulnerable populations.

The SCORCH Program: Phase 2 aims to enhance the understanding of single cell biology in the context of HIV and Substance Use Disorder (SUD). Building on previous research, this initiative will explore new single cell approaches to investigate the interactions between SUD and HIV progression at various biological levels. By leveraging advanced techniques, the program seeks to identify candidate mechanisms and potential therapeutic targets, ultimately contributing to innovative solutions for SUDs and HIV-related challenges.

This funding opportunity aims to support Early Stage Investigators (ESIs) in conducting preclinical HIV/AIDS research using Nonhuman Primate (NHP) models. Eligible applicants must have at least two years of postdoctoral experience and be within ten years of their terminal degree. The initiative aligns with the NIH Strategic Plan for HIV and HIV-Related Research, targeting the reduction of HIV incidence, development of therapies, and advancement in research areas related to HIV.

The National Institute on Drug Abuse (NIDA) invites applications for longitudinal cohort studies focusing on HIV and substance use. This initiative aims to foster multidisciplinary research addressing HIV-associated co-morbidities and substance use disorders. The program encourages collaboration with a NIDA-funded Coordinating Center to enhance research agendas that align with NIH-HIV priorities, ensuring impactful policy and practice outcomes in the field of HIV/AIDS and substance use.

The High Priority HIV and Substance Use Research funding opportunity aims to support innovative research that addresses the intersection of HIV and substance use. Researchers are encouraged to submit proposals that include a detailed research plan and preliminary data, exploring new avenues for prevention, treatment, and potential cures for HIV among people who use drugs. Applications are due by 5 PM local time, with optional Letters of Intent recommended 30 days prior.

The Limited Competition NOFO aims to provide ongoing support for specific pathogen-free (SPF) macaque colonies that facilitate vital HIV/AIDS research. Only recipients funded under previous ORIP-supported SPF colony announcements are eligible to apply. These breeding colonies are crucial for maintaining SPF macaques, which are free from certain viruses that could jeopardize research outcomes. The project emphasizes the genetic characterization of macaques to enhance understanding of immune responses related to HIV and SIV.